Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qi-xue run-chang is a Traditional Chinese Medicine (TCM) herbal formulation primarily used for the treatment of functional constipation, particularly in elderly patients or those exhibiting patterns of 'Qi and Blood deficiency' according to TCM principles. The formulation typically consists of a complex blend of botanical extracts, including *Astragalus membranaceus* (Huangqi), *Angelica sinensis* (Danggui), *Cannabis sativa* seeds (Huomaren), *Cistanche deserticola* (Roucongrong), *Prunus persica* seeds (Tao Ren), and *Rehmannia glutinosa* (Sheng Di Huang). Its therapeutic mechanism involves tonifying the body's vital energy (Qi) and blood while providing a lubricating effect on the intestinal tract to facilitate stool passage and promote peristalsis. It is widely available in China as an over-the-counter (OTC) patent medicine, most commonly in capsule or oral liquid dosage forms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qixue runchang.